ARCHIVES

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

FDA Designates Zometa For Priority Review.

November 30, 2001

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

National Action Plan Issues RFA For Grant Supplements

April 21, 1995

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987